![Hiroki Narita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiroki Narita
Direktor/Vorstandsmitglied bei
Cardio, Inc.
Profil
Hiroki Narita is currently the Director at Cardio, Inc. and the Senior Managing Director at Daiwa Corporate Investment Co., Ltd. He previously held positions as an Outside Director at REGiMMUNE Corp., an Outside Director at TMRC Co. Ltd., a Director at Ribomic, Inc., an Outside Director at RaQualia Pharma, Inc., and a Deputy General Manager at Daiwa SMBC Capital Co., Ltd. Mr. Narita completed his undergraduate degree at Aoyama Gakuin University.
Aktive Positionen von Hiroki Narita
| Unternehmen | Position | Beginn |
|---|---|---|
Cardio, Inc. | Direktor/Vorstandsmitglied | 15.07.2009 |
Daiwa Corporate Investment Co., Ltd.
 Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment invests in companies located in Japan. The firm focuses on a broad range of sectors and Industries. It provides financing for buyout, early and growth stage capital requirements. | Private Equity Investor | 01.04.2022 |
Ehemalige bekannte Positionen von Hiroki Narita
| Unternehmen | Position | Ende |
|---|---|---|
| RAQUALIA PHARMA INC. | Direktor/Vorstandsmitglied | 31.10.2011 |
TMRC Co. Ltd.
 TMRC Co. Ltd. BiotechnologyHealth Technology Operates as a pharma company that researches and develops anti-cancer drugs | Direktor/Vorstandsmitglied | - |
Daiwa SMBC Capital Co., Ltd.
 Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Corporate Officer/Principal | - |
| RIBOMIC INC. | Direktor/Vorstandsmitglied | - |
REGiMMUNE Corp.
 REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Direktor/Vorstandsmitglied | - |
Ausbildung von Hiroki Narita
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Daiwa SMBC Capital Co., Ltd.
Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Finance |
Aoyama Gakuin University
 Aoyama Gakuin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REGiMMUNE Corp.
REGiMMUNE Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops immune medicines | Health Technology |
TMRC Co. Ltd.
TMRC Co. Ltd. BiotechnologyHealth Technology Operates as a pharma company that researches and develops anti-cancer drugs | Health Technology |
Ribomic, Inc.
 Ribomic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures aptamer drug | Health Technology |
Cardio, Inc. | |
Daiwa Corporate Investment Co., Ltd.
Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment invests in companies located in Japan. The firm focuses on a broad range of sectors and Industries. It provides financing for buyout, early and growth stage capital requirements. | Finance |
RaQualia Pharma, Inc.
 RaQualia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of medicines | Health Technology |
